Viral Targeting of Glioblastoma Stem Cells with Patient-Specific Genetic and Post-Translational p53 Deregulations

The authors dissected the genetic and functional heterogeneity of human glioblastoma stem cells within patients by their innate responses to non-pathogenic mouse parvoviruses that were tightly restrained by cellular physiology.